BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2004
View Archived Issues
Promising new antibiotic against drug-resistant Gram-positive and -negative pathogens
Read More
Phase IIb RA study of Rituxan meets primary endpoint
Read More
Phase II multidose study planned for exenatide LAR in 2005
Read More
Approvable letter for Ralivia ER
Read More
New anticancer and immunostimulant agent isolated from plants by Japanese team
Read More
New inhibitors of PDE4, MMP and/or TNF-alpha discovered at Celgene
Read More
Novel ZAP70 and Syk kinase inhibitors under study at Kissei
Read More
Pfizer researchers describe new beta2-adrenoceptor agonists and their use
Read More
Novel TGF-beta receptor type II kinase inhibitors claimed by Pfizer
Read More
Vertex patent covers novel GSK-3 inhibitors and their use in stroke, AD, diabetes, etc.
Read More
Novel IgE production inhibitors prepared and tested at Dainippon
Read More
Shionogi scientists present new HIV integrase inhibitors
Read More
Low-frequency CERA dosing effective in chronic kidney disease patients
Read More
SR-121463 beneficial in SIADH patients
Read More
Dialysis hypotension improves with FK-352
Read More
Studies reveal efficacy of pyridoxamine in diabetic nephropathy
Read More
Merck identifies centrally acting allosteric mGluR5 modulators
Read More
Natural protease inhibitors may enhance chemotherapeutic efficacy
Read More
Novel methionyl tRNA synthetase inhibitor REP-8839 shows potent antibacterial activity
Read More
Aldosterone inhibitor may ameliorate hypertension-induced end-organ damage
Read More
Schering-Plough and ViroPharma finalize pleconaril license agreement
Read More
Sonus to acquire Synt:em
Read More
Genzyme seeks additional indication for Thyrogen
Read More
Mitsubishi Pharma and Takeda terminate license agreement for oral MCC-135
Read More
Taxotere approved in E.U. for prostate cancer
Read More
Alza enters into option and license agreement with Ardent for DPI-125
Read More
Norak Biosciences in second license agreement with AstraZeneca
Read More
spi-VEC oral hepatitis B vaccine shows promise in phase I study
Read More
X-Ceptor researchers identify potent and selective inverse agonist of ERRalpha
Read More
Good tolerability profile reported for DepoDur after lower abdominal surgery
Read More
Two-year results of the TEMPO trial confirm the efficacy of etanercept plus methotrexate in RA
Read More
Update on the clinical development of tefibazumab for S. aureus infections
Read More